tirzepatide in the news Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). device gives patients an additional, potentially more convenient option for taking the drug: They can FDA approves new obesity drug

University Health starts $450M expansion at Retama Hospital in Northeast San Antonio SAN ANTONIO - University Health has taken a significant step forward in expanding its healthcare services with the groundbreaking ceremony for the University Health Retama Hospital and Medical Office Building

Many respondents (76%) said theres stigma around using GLP-1s, and 89% said theres still a stigma surrounding obesity

Small molecule orforglipron could provide the lower COGS and financial headroom to do so and retain an acceptable margin

Reports suggest that roughly one in five peptide shipments from unverified Chinese suppliers arrives with documentation that does not match the actual product